Piper Jaffray Starts AcelRx Pharmaceuticals (ACRX) at Overweight
Tweet
Share
E-mailGet Alerts ACRX Hot Sheet
Price: $0.86 --0%
Rating Summary:
10 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 15 | New: 6
Rating Summary:
10 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 15 | New: 6
Join SI Premium – FREE
Piper Jaffray initiates coverage on AcelRx Pharmaceuticals (NASDAQ: ACRX) with an Overweight. PT $7.
For more ratings news on AcelRx Pharmaceuticals click here and for the rating history of AcelRx Pharmaceuticals click here.
Shares of AcelRx Pharmaceuticals closed at $3.33 yesterday.
For more ratings news on AcelRx Pharmaceuticals click here and for the rating history of AcelRx Pharmaceuticals click here.
Shares of AcelRx Pharmaceuticals closed at $3.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Starts Jasper Therapeutics (JSPR) at Overweight
- JPMorgan Resumes Take-Two Interactive (TTWO) at Overweight
- Craig-Hallum Starts Alterity Therapeutics (ATHE) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
